KalVista Pharmaceuticals, Inc. Annual Income Tax Expense (Benefit) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
KalVista Pharmaceuticals, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2013 to 2023.
  • KalVista Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending January 31, 2017 was $0.000.
  • KalVista Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • KalVista Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • KalVista Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 May 1, 2023 Apr 30, 2024 10-K 2024-07-11
2022 $0 $0 May 1, 2022 Apr 30, 2023 10-K 2024-07-11
2021 $0 $0 May 1, 2021 Apr 30, 2022 10-K 2024-07-11
2020 $0 +$124K May 1, 2020 Apr 30, 2021 10-K 2023-07-10
2019 -$124K -$248K -200% May 1, 2019 Apr 30, 2020 10-K 2022-07-07
2018 $124K +$124K May 1, 2018 Apr 30, 2019 10-K 2021-07-13
2017 $0 $0 May 1, 2017 Apr 30, 2018 10-K 2018-07-30
2016 $0 $0 May 1, 2016 Apr 30, 2017 10-K 2018-07-30
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2016-03-30
2014 $0 $0 Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 $0 Jan 1, 2013 Dec 31, 2013 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.